Reuters logo
BRIEF-Cadila Healthcare says Zydus gets final USFDA nod for Cholestyramine
April 26, 2017 / 11:25 AM / in 6 months

BRIEF-Cadila Healthcare says Zydus gets final USFDA nod for Cholestyramine

April 26 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus receives final approval from the USFDA for Cholestyramine for oral suspension USP

* Says Cholestyramine will be produced at group's formulations making facility at Baddi Source text: bit.ly/2pyJjAT Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below